I was wondering what this person's explanation was for the increased numbers of autistic children, and found the whole study here--
http://www.blackwell-synergy.com/doi/full/10.1111/j.1420-9101.2006.01091.x?cookieSet=1 They certainly don't think it is *only* genetic--
Several lines of evidence implicate dysregulated methylation, and imprinting effects, in environmental determinants on autism. First, valproic acid induces autism when administered in early foetal development (Ingram et al., 2000b; Chudley, 2004; Schneider & Przewlocki, 2005), apparently via its role as a specific inhibitor of histone deacetylase activity, which reduces methylation of promotor regions (Detich et al., 2003). Experiments with mice indicate that effects of valproic acid on genomically imprinted genes contribute to its neurological effects (Beck, 2001), which include abnormalities in serotoninergic neurone development and hyperserotonaemia (Miyazaki et al., 2005). Thalidomide, which similarly leads to autism via perturbation of early brain development, exerts similar effects on the serotoninergic system (Narita et al., 2002; Miyazaki et al., 2005).
Second, impaired methionine metabolism, caused by heavy metals, thimerosal and other agents, and mediated by genetic factors such as propensity to autoimmune disease (Hornig et al., 2004), abnormal metal metabolism (Serajee et al., 2004), or adenosine deaminase activity, may cause dysregulated methylation and contribute to autism (Waly et al., 2004).
Third, autism increases with paternal (and maternal) age (Gillberg, 1980), and assisted reproduction via intracytoplasmic sperm injection (ICSI) may increase the risk for syndromes of dysregulated imprinting, including Angelman and Beckwith-Weideman (Paoloni-Giacobino & Chaillet, 2004; Waterland & Jirtle, 2004; Maher, 2005). Both paternal age and ICSI are expected to contribute to methylated-gene defects, which may include effects on brain-imprinted genes (Waterland & Jirtle, 2004; Malaspina et al., 2005).
Finally, James et al. (2004) demonstrated impaired methylation capacity in children with autism; altered methylation, and its effects on imprinted gene expression, can persist through development (Waterland & Jirtle, 2004). Monozygotic twins have also recently been demonstrated to diverge in their patterns of gene methylation starting in early development, which may contribute to their divergence in the expression of cognitive disorders (Petronis et al., 2003; Fraga et al., 2005; Wong et al., 2005).